Literature DB >> 2846656

Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate.

S M Sadrzadeh1, J W Eaton.   

Abstract

Hemorrhage within the central nervous system (CNS) may be associated with subsequent development of seizure states or paralysis. Prior investigations indicate that hemoglobin, released from extravasated erythrocytes, may be toxic to the CNS by promoting peroxidation of lipids and inhibition of Na,K-ATPase. These deleterious effects are blocked both in vitro and in vivo by the Fe3+ chelator, desferrioxamine, indicating the involvement of free iron derived from hemoglobin. We now report that the Fe2+ chelator, ferene, also inhibits methemoglobin- and ferric iron-mediated CNS lipid oxidation, reflecting the reduction of Fe3+ by some component of the CNS. This reduction is apparent in the accumulation of the highly chromophoric ferene: Fe2+ chelate after the addition of Fe3+ salts to supernatants of murine brain homogenates. Because large amounts of ascorbic acid occur in mammalian CNS, we suspected that this reducing substance might be responsible. Indeed, the peroxidative effects of hemoglobin and iron on murine brain are blocked by washing of CNS membranes or by preincubation of crude homogenates with ascorbate oxidase. Furthermore, the addition of ascorbate to washed CNS membranes fully restores hemoglobin/iron-driven peroxidation. We conclude that posthemorrhagic CNS dysfunction may stem from damaging redox reactions between hemoglobin iron, ascorbic acid, and oxidizable components of the nervous system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2846656      PMCID: PMC442716          DOI: 10.1172/JCI113759

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Focal epileptogenesis after intracortical hemoglobin injection.

Authors:  A D Rosen; N V Frumin
Journal:  Exp Neurol       Date:  1979-11       Impact factor: 5.330

2.  The binding of azide to human methemoglobin A0. Error analysis for the interpolative and noninterpolative methods.

Authors:  A D Barksdale; B E Hedlund; B E Hallaway; E S Benson; A Rosenberg
Journal:  Biochemistry       Date:  1975-06-17       Impact factor: 3.162

3.  Ascorbic acid--a naturally occurring mediator of lipid peroxide formation in rat brain.

Authors:  O P Sharma; C R Krishna Murti
Journal:  J Neurochem       Date:  1976-07       Impact factor: 5.372

4.  Accelerated autoxidation and heme loss due to instability of sickle hemoglobin.

Authors:  R P Hebbel; W T Morgan; J W Eaton; B E Hedlund
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

5.  A rapid manual method for routine assay of ascorbic acid in serum and plasma.

Authors:  B R Day; D R Williams; C A Marsh
Journal:  Clin Biochem       Date:  1979-02       Impact factor: 3.281

6.  The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide.

Authors:  G Minotti; S D Aust
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

7.  Neuronophagia by leukocytes in experimental spinal cord injury.

Authors:  E D Means; D K Anderson
Journal:  J Neuropathol Exp Neurol       Date:  1983-11       Impact factor: 3.685

8.  Redox cycling and lipid peroxidation: the central role of iron chelates.

Authors:  J R Bucher; M Tien; L A Morehouse; S D Aust
Journal:  Fundam Appl Toxicol       Date:  1983 Jul-Aug

9.  Lipid peroxidation in rat tissue homogenates: Interaction of iron and ascorbic acid as the normal catalytic mechanism.

Authors:  A A Barber
Journal:  Lipids       Date:  1966-03       Impact factor: 1.880

10.  The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron.

Authors:  J R Bucher; M Tien; S D Aust
Journal:  Biochem Biophys Res Commun       Date:  1983-03-29       Impact factor: 3.575

View more
  23 in total

1.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

Review 2.  Antioxidant therapies for acute spinal cord injury.

Authors:  Edward D Hall
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

3.  Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.

Authors:  Jian Wang; Sylvain Doré
Journal:  Brain       Date:  2007-06       Impact factor: 13.501

Review 4.  Role of oxidative stress in epileptic seizures.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yoon Hee Chung; Won-Ki Kim; Kwang-Ho Ko; Jae-Hyung Bach; Jau-Shyong Hong; Yukio Yoneda; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

Review 5.  Antioxidant therapies for traumatic brain injury.

Authors:  Edward D Hall; Radhika A Vaishnav; Ayman G Mustafa
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

6.  Fe-catalyzed cleavage of the alpha subunit of Na/K-ATPase: evidence for conformation-sensitive interactions between cytoplasmic domains.

Authors:  R Goldshleger; S J Karlish
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 7.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

8.  Vitamin C deficiency: more than just a nutritional disorder.

Authors:  Joris R Delanghe; Michel R Langlois; Marc L De Buyzere; Na Na; Jin Ouyang; Marijn M Speeckaert; Mathieu A Torck
Journal:  Genes Nutr       Date:  2011-05-26       Impact factor: 5.523

9.  Hemoglobin toxicity in experimental bacterial peritonitis is due to production of reactive oxygen species.

Authors:  Y M Yoo; K M Kim; S S Kim; J A Han; H Z Lea; Y M Kim
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 10.  Heme degradation and vascular injury.

Authors:  John D Belcher; Joan D Beckman; Gyorgy Balla; Jozsef Balla; Gregory Vercellotti
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.